The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy.
Open accessAbstract
BACKGROUND: Enteroviral RNA sequences have been demonstrated in the myocardium of patients with myocarditis or dilated cardiomyopathy from presentation to end-stage disease. The prognosis of heart muscle disease has not previously been evaluated in relation to the detection of enterovirus in myocardial biopsy tissue. METHODS AND RESULTS: We studied 123 consecutive patients with heart muscle disease prospectively. Multiple endomyocardial biopsy samples taken from all patients during diagnostic cardiac catheterization were classified histologically and were examined for enteroviral RNA by use of an enterovirus group-specific hybridization probe. Three enterovirus-negative patients with cardiac amyloidosis were excluded from subsequent analysis. Enteroviral RNA sequences were detectable in 41 (34%) of the remaining 120 patients (group A), while 79 (66%) had no virus detected (group B). The groups did not differ significantly in age, sex, symptomatic presentation, or hemodynamic characteristics; duration of symptoms was significantly shorter in group A (7.8 +/- 9.6 versus 14.9 +/- 19.0 months, P < .05). At follow-up (mean, 25 months; range, 11 to 50 months), patients from group A had an increased mortality compared with those in group B (25% versus 4%, respectively; P = .02). Mortality was also statistically greater in patients with symptomatic cardiac failure (P = .02), those with elevated left ventricular end-diastolic pressures (P = .03), and those in New York Heart Association functional classes III and IV (P = .05). Multivariate regression analysis, however, showed that only the presence of enterovirus RNA and symptomatic heart failure were of independent prognostic value. CONCLUSIONS: These data demonstrate that the detection of enterovirus RNA in the myocardium of patients with heart muscle disease at the time of initial investigation is associated with an adverse prognosis and that the presence of enterovirus RNA is an independent predictor of clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
The use of single plane angiocardiograms for the calculation of left ventricular volume in man
Sandler, H., & Dodge, H. T. (1968) · American Heart Journal · doi:10.1016/0002-8703(68)90089-6 · Cited by 1,069
The natural history of idiopathic dilated cardiomyopathy
Fuster, V., Gersh, B. J., Giuliani, E. R., Tajik, A. J., Brandenburg, R. O., & Frye, R. L. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90534-8 · Cited by 943
Bowles, N. E., Olsen, E. G. J., Richardson, P. J., & Archard, L. C. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91837-4 · Cited by 602
Self-citationFactors influencing the one-year mortality of dilated cardiomyopathy
Unverferth, D. V., Magorien, R. D., Moeschberger, M. L., Baker, P. B., Fetters, J. K., & Leier, C. V. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90320-5 · Cited by 546
Cardiac failure and sudden death in the Framingham Study
Kannel, W. B., Plehn, J. F., & Cupples, L. A. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90891-5 · Cited by 327
SURMA AND BLOOD LEAD IN CHILDREN
Aslam, M., Healy, M. A., Davis, S. S., & Ali, A. R. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91156-3 · Cited by 313
Antibodies to Coxsackie B viruses in congestive cardiomyopathy.
Cambridge, G., MacArthur, C. G., Waterson, A. P., Goodwin, J. F., & Oakley, C. M. (1979) · Heart · doi:10.1136/hrt.41.6.692 · Cited by 241
Kandolf, R., & Hofschneider, P. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.14.4818 · Cited by 224
Brigden, W., & Robinson, J. (1964) · BMJ · doi:10.1136/bmj.2.5420.1283 · Cited by 190
Sudden death in idiopathic dilated cardiomyopathy
Tamburro, P., & Wilber, D. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90989-9 · Cited by 166
Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes.
Kaczmarek, L., Calabretta, B., & Baserga, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5375 · Cited by 144
Cunningham, L., Bowles, N. E., Lane, R. J. M., Dubowitz, V., & ARCHARD, L. C. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-6-1399 · Cited by 139
Self-citationFactors predicting mortality in idiopathic dilated cardiomyopathy
Michel Komajda, N., Jaïs, J., Reeves, F., GOLDFARB, B., Bouhour, J. B., JUILLIERES, Y., Lanfranchi, J., Peycelon, P., Geslin, P., Carrié, D., et al. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059803 · Cited by 133
KING'S ENDOMYOCARDIAL BIOPTOME
Richardson, P. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)93204-8 · Cited by 133
Self-citationDetection of Coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction.
Weiss, L. M., Movahed, L. A., Billingham, M. E., & Cleary, M. L. (1991) · PubMed Central · Cited by 117
Latham, R. D., Mulrow, J. P., Virmani, R., Robinowitz, M., & Moody, J. M. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90626-1 · Cited by 85
Lie, J. T. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-7-525 · Cited by 84
Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes
Löhr, M. J., & Oldstone, M. B. A. (1990) · The Lancet · doi:10.1016/0140-6736(90)92145-8 · Cited by 53
Clinical outcome and left ventricular function 23 years after acute Coxsackie virus myopericarditis
Remes, J., Helin, M., VAINO, P., & Rautio, P. (1990) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a059675 · Cited by 51
Popma, J. J., Cigarroa, R. G., Buja, L. M., & Hillis, L. D. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90147-1 · Cited by 39
Histopathologic aspects of viral myocarditis and its diagnostic criteria
Olsen, E. G. J. (1985) · Heart and Vessels · doi:10.1007/bf02072379 · Cited by 12
Self-citationMontague, T. J., Lopaschuk, G. D., & Davies, N. J. (1990) · CHEST Journal · doi:10.1378/chest.98.1.190 · Cited by 7
Cited by
Feldman, A. M., & McNamara, D. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431908 · Cited by 958
Kühl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, T., Lassner, D., Poller, W., Kandolf, R., & Schultheiss, H.-P. (2005) · Circulation · doi:10.1161/01.cir.0000155616.07901.35 · Cited by 712
Viral myocarditis—diagnosis, treatment options, and current controversies
Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657
Myocarditis: Current Trends in Diagnosis and Treatment
Magnani, J. W., & Dec, G. W. (2006) · Circulation · doi:10.1161/circulationaha.105.584532 · Cited by 610
Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction
Kühl, U., Pauschinger, M., Seeberg, B., Lassner, D., Noutsias, M., Poller, W., & Schultheiss, H.-P. (2005) · Circulation · doi:10.1161/circulationaha.105.548156 · Cited by 603
Metadata
- Authors
- Why, H. J., Meany, B. T., Richardson, P. J., Olsen, E. G., Bowles, N. E., Cunningham, L., Freeke, C. A., & Archard, L. C.
- Venue
- Circulation
- Published
- 1994-06
- Volume
- 89
- Issue
- 6
- Pages
- 2582-2589
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2020780227
- Cited by
- 272
- References
- 23
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.